Skip to main content

Site notifications

ArmaForce for Juniors (FIT-BioCeuticals Pty Ltd)

Product Name
ArmaForce for Juniors
ARTG details
  • 300729
Date of review outcome
Date of publication
Jun-2025
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, if you follow the recommended actions below
What action should consumers take?
Be aware that the claims for reducing free radical damage to body cells and its traditional use in reducing mild throat inflammation in children were not substantiated by the sponsor
Review scope
Targeted
Information reviewed
ARTG Record, Advertising (other), Evidence, Labels, Manufacturing Documentation, Website
Issues related to safety
None
Issues related to efficacy
The sponsor did not hold sufficient evidence to support the claims outlined in ‘What action should consumers take?’ above. The evidence provided was not of sufficient quality.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor corrected some of the issues and responded with more information. The TGA issued an educational letter outlining the remaining issues. The sponsor responded with more information and no further action was required. The sponsor cancelled this medicine and withdrew it from further supply.